Heart Failure

Consumption of the artificial sweetener erythritol may be linked with higher risk for blood clot formation compared with glucose in a study of 20 healthy volunteers published in Applied Microbiology and Biotechnology.

Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open.

scPharmaceuticals Inc. announced the FDA approved the supplemental new drug application to expand the indication of its self-administered subcutaneous furosemide injection for patients with heart failure.

Ambient air pollution was associated with an increased risk for adverse events among Medicare beneficiaries with preexisting HF, according to a study published in the Journal of the American Heart Association.

The first implantation of a new class of total artificial heart, a rotary pump with a single moving part, was successfully completed by a team at The Texas Heart Institute, the institution reported.

Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.

Hyperkalemia may be considered a common occurrence in patients with chronic kidney disease, particularly in those with heart failure or diabetes, published data show.

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.

Increased vitamin A intake may play a role in reducing depressive symptoms in patients with heart failure, according to a cross-sectional study published in ESC: Heart Failure.